The World Health Organization announced it is recommending the broad use of the first proven malaria vaccine.
Produced by pharmaceutical giant GSK, it will be used to help children in Africa after pilots in three countries found it reduced cases by 40%.
The head of the WHO Tedros Adhanom Ghebreyesus, who began his career as a malaria researcher, described the vaccine as a major breakthrough and a gift to the world.